Blue Owl Capital Holdings LP
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 11, 2026), Blue Owl Capital Holdings LP reported 48 stock positions worth $656.7 million. Its top holding was Space Exploration Techn Class A (SPCX) at 36.4% of the portfolio, followed by Aktis Oncology (AKTS, 15.1%) and Cullinan Therapeutics (CGEM, 4.3%). Compared with Q1 2026, it opened 12 new positions, sold out of 17, added to 11 and reduced 11. The biggest buy was a new position in Space Exploration Techn Class A (SPCX) and the biggest sale an exit from Engene (ENGN).
- Most Recent 13F
- Q2 2026
- Location
- New York, NY
- CIK
- 0001858703
- Portfolio Value
- $656.7M (Q2 2026)
- SEC Filing
- 0001193125-26-345031 ↗ filed Aug 11, 2026
Holdings Value
Holdings 48 stocks · $656.7M
| SPCX Space Exploration Techn Class A | 36.40% | 1,398,815 | $239.0M | New |
| AKTS Aktis Oncology Inc. | 15.07% | 3,070,219 | $99.0M | Reduce -2.9% |
| CGEM Cullinan Therapeutics Inc. | 4.27% | 1,539,764 | $28.0M | Reduce -19.4% |
| LRMR Larimar Therapeutics Inc. | 4.26% | 9,163,157 | $27.9M | Add +28.7% |
| NCDL Nuveen Churchill Direct Lend | 4.05% | 2,143,626 | $26.6M | No change |
| MPLT Maplight Therapeutics Inc. | 3.98% | 729,929 | $26.2M | Reduce -27.4% |
| COF Capital One Financial Corp. | 3.66% | 119,757 | $24.0M | New |
| OBDC Blue Owl Capital Corp. | 3.39% | 2,045,070 | $22.2M | No change |
| FISN Deep Fission Inc. | 2.24% | 1,333,333 | $14.7M | New |
| DELL Dell Technologies -C | 2.17% | 32,961 | $14.2M | Add +137.2% |
| HLLY Holley Inc. | 1.70% | 4,376,888 | $11.2M | Add +3.3% |
| EYPT Eyepoint Inc. | 1.66% | 762,594 | $10.9M | Reduce -16.4% |
| SGMT Sagimet Biosciences Inc. Class A | 1.48% | 1,260,544 | $9.7M | Add +277.6% |
| CRVS Corvus Pharmaceuticals Inc. | 1.38% | 608,600 | $9.1M | Add +11.7% |
| ARTV Artiva Biotherapeutics Inc. | 1.29% | 874,542 | $8.5M | New |
| CMPX Compass Therapeutics Inc. | 1.21% | 3,624,076 | $7.9M | Add +23.2% |
| CNDT Conduent Inc. | 1.12% | 5,036,595 | $7.4M | No change |
| RYTM Rhythm Pharmaceuticals Inc. | 1.04% | 61,455 | $6.8M | No change |
| CMPS Compass Pathways PLC | 0.97% | 450,000 | $6.4M | New |
| RARE Ultragenyx Pharmaceutical Inc. | 0.93% | 182,638 | $6.1M | Reduce -39.6% |
| PVLA Palvella Therapeutics Inc. | 0.84% | 36,259 | $5.5M | Add +16.0% |
| IMA Imagenebio Inc. | 0.82% | 917,692 | $5.4M | Reduce -4.3% |
| VRDN Viridian Therapeutics Inc. | 0.73% | 260,000 | $4.8M | New |
| IMMX Immix Biopharma Inc. | 0.69% | 437,552 | $4.5M | Reduce -20.1% |
| ORIC Oric Pharmaceuticals Inc. | 0.66% | 400,000 | $4.3M | Add +166.7% |
| LENZ Lenz Therapeutics Inc. | 0.65% | 756,722 | $4.3M | Add +49.3% |
| AQST Aquestive Therapeutics Inc. | 0.60% | 942,932 | $3.9M | Reduce -30.1% |
| STWD Starwood Property Trust Inc. | 0.49% | 196,355 | $3.2M | Add +23.9% |
| EVMN Evommune Inc. | 0.36% | 180,000 | $2.4M | Add +80.0% |
| ELDN Eledon Pharmaceuticals Inc. | 0.34% | 566,509 | $2.2M | Reduce -60.1% |
| CABA Cabaletta Bio Inc. | 0.34% | 714,710 | $2.2M | New |
| CHYM Chime Financial Inc. Class A | 0.28% | 89,878 | $1.8M | New |
| CNTX Context Therapeutics Inc. | 0.25% | 2,934,015 | $1.6M | Reduce -42.4% |
| WW WW International Inc.-New filed as WW INTL INC | 0.21% | 84,399 | $1.3M | Reduce -11.8% |
| MRKR Marker Therapeutics Inc. | 0.12% | 554,250 | $815K | No change |
| ADCT Adc Therapeutics SA | 0.12% | 733,568 | $785K | No change |
| HELP Cybin Inc. | 0.06% | 59,911 | $396K | New |
| FLD Fold Holdings Inc. filed as FOLD HLDGS INC | 0.06% | 856,632 | $385K | No change |
| PIPR Piper Sandler Cos | 0.03% | 2,428 | $176K | No change |
| CELC Celcuity Inc. | 0.02% | 1,249 | $131K | New |
| ET Energy Transfer LP | 0.02% | 5,326 | $102K | No change |
| CAI Caris Life Sciences Inc. | 0.01% | 4,711 | $84K | No change |
| VOD Vodafone Group PLC-SP ADR | 0.01% | 5,371 | $71K | New |
| MRNO Murano Global Investments PL | 0.01% | 261,875 | $63K | New |
| AMOD Alpha Modus Holdings Inc. | 0.01% | 9,853 | $42K | No change |
| AEON Aeon Biopharma Inc. | 0.00% | 42,353 | $30K | No change |
| SHFS SHF Holdings Inc. | 0.00% | 75,897 | $18K | No change |
| KPLT Katapult Holdings Inc. | 0.00% | 5,421 | $5K | No change |
Options reported separately and not counted above: COMPASS PATHWAYS PLC calls ($5.2M), ERASCA INC calls ($795K), ELEDON PHARMACEUTICALS INC calls ($285K), LARIMAR THERAPEUTICS INC calls ($146K), COMPASS THERAPEUTICS INC calls ($106K).
Other holdings (23): bonds, preferreds, convertibles and warrants · $1.3M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| NIOBW Niocorp Developments Ltd. -28 | *W EXP 03/17/202 | 268,280 | $381K | Reduce -16.2% |
| RZLVW Rezolve AI PLC -CW27 | *W EXP 08/15/202 | 235,121 | $214K | No change |
| BNAIW Brand Engagement Netwo -CW27 | *W EXP 03/14/202 | 1,453,808 | $204K | Reduce -12.8% |
| ENGNW Engene Holdings Inc.-28 | *W EXP 10/31/202 | 511,177 | $148K | No change |
| USDEW Stablecoinx Inc. | *W EXP 06/25/203 | 250,000 | $103K | New |
| DAVEW Dave Inc. -CW27 | *W EXP 01/05/202 | 28,750 | $68K | No change |
| AMODW Insight Acquisition Co. -CW23 | *W EXP 12/13/202 | 1,854,665 | $56K | No change |
| RDZNW Vahanna Tech Edge -CW24 | *W EXP 11/30/202 | 225,000 | $43K | No change |
| SLND.WS Legato Merger Corp. II -CW23 | *W EXP 02/14/202 | 860,302 | $26K | No change |
| BGLWW Blue Gold Ltd. | *W EXP 04/01/203 | 175,000 | $21K | No change |
| BKSYW Blacksky Technology -CW24 | *W EXP 09/09/202 | 350,000 | $18K | No change |
| TVGNW Semper Paratus Acqu -CW26 | *W EXP 02/14/202 | 200,000 | $12K | No change |
| ZEOWW Esgen Acquisition A -CW23 | *W EXP 03/13/202 | 250,000 | $10K | New |
| LVWR.WS Livewire Group Inc.-27 | *W EXP 09/26/202 | 400,000 | $8K | New |
| NVNWF Nvni Group Ltd.-28 | *W EXP 11/01/202 | 200,000 | $6K | New |
| DAICW Cid Holdco Inc. -26 | *W EXP 12/31/202 | 444,515 | $4K | No change |
| BDMDW Baird Medical Investment -28 | *W EXP 10/01/202 | 100,000 | $4K | No change |
| PGYWW Pagaya Technologies Ltd. -27 | *W EXP 99/99/999 | 48,661 | $2K | No change |
| SDSTW Global Partner Acq A -CW27 | *W EXP 06/21/202 | 16,666 | $2K | No change |
| LIMNW Liminatus Pharma Inc. Class A-28 | *W EXP 04/30/203 | 50,000 | $2K | No change |
| MLKWF Waldencast Acq Class A -CW27 | *W EXP 07/27/202 | 33,333 | $2K | No change |
| XBPEW CF Acquisition Viii A -CW27 | *W EXP 11/30/202 | 24,778 | $1K | No change |
| ASBPW Aspire Biopharma Holdin-CW27 | *W EXP 02/14/203 | 50,000 | $1K | No change |
Total filed on the 13F, all lines: $658.0M.
Portfolio Sells Q1 2026 → Q2 2026
| ENGN Engene Holdings Inc. | Sold out | 0.00% | −8.13 |
| CNTX Context Therapeutics Inc. | Reduce -42.4% | 0.25% | −3.36 |
| CGEM Cullinan Therapeutics Inc. | Reduce -19.4% | 4.27% | −3.07 |
| MPLT Maplight Therapeutics Inc. | Reduce -27.4% | 3.98% | −1.54 |
| EYPT Eyepoint Inc. | Reduce -16.4% | 1.66% | −1.52 |
| COMPASS PATHWAYS PLC | Sold out | 0.00% | −1.39 |
| CVEO Civeo Corp. | Sold out | 0.00% | −1.29 |
| KALV Kalvista Pharmaceuticals Inc. | Sold out | 0.00% | −1.17 |
| OVID Ovid Therapeutics Inc. | Sold out | 0.00% | −1.14 |
| PLRX Pliant Therapeutics Inc. | Sold out | 0.00% | −1.01 |
| AQST Aquestive Therapeutics Inc. | Reduce -30.1% | 0.60% | −0.91 |
| ELDN Eledon Pharmaceuticals Inc. | Reduce -60.1% | 0.34% | −0.84 |
| RARE Ultragenyx Pharmaceutical Inc. | Reduce -39.6% | 0.93% | −0.79 |
| IMMX Immix Biopharma Inc. | Reduce -20.1% | 0.69% | −0.66 |
| LARIMAR THERAPEUTICS INC | Sold out | 0.00% | −0.52 |
| IMA Imagenebio Inc. | Reduce -4.3% | 0.82% | −0.47 |
| EPD Enterprise Products Partners | Sold out | 0.00% | −0.32 |
| AKTS Aktis Oncology Inc. | Reduce -2.9% | 15.07% | −0.22 |
| MINERALYS THERAPEUTICS INC | Sold out | 0.00% | −0.16 |
| WW WW International Inc.-New | Reduce -11.8% | 0.21% | −0.15 |
| COMPASS THERAPEUTICS INC | Sold out | 0.00% | −0.14 |
| CAH Cardinal Health Inc. | Sold out | 0.00% | −0.10 |
| CID HOLDCO INC | Sold out | 0.00% | −0.03 |
| VODAFONE GROUP PLC | Sold out | 0.00% | −0.02 |
| VIKING THERAPEUTICS INC | Sold out | 0.00% | −0.02 |
| GOCOQ Gohealth Inc. Class A | Sold out | 0.00% | −0.02 |
| STRUCTURE THERAPEUTICS INC | Sold out | 0.00% | −0.01 |
| OLEMA PHARMACEUTICALS INC | Sold out | 0.00% | −0.00 |
Portfolio Buys Q1 2026 → Q2 2026
| SPCX Space Exploration Techn Class A | New | 36.40% | +36.40 |
| COF Capital One Financial Corp. | New | 3.66% | +3.66 |
| FISN Deep Fission Inc. | New | 2.24% | +2.24 |
| DELL Dell Technologies -C | Add +137.2% | 2.17% | +1.55 |
| ARTV Artiva Biotherapeutics Inc. | New | 1.29% | +1.29 |
| SGMT Sagimet Biosciences Inc. Class A | Add +277.6% | 1.48% | +1.01 |
| CMPS Compass Pathways PLC | New | 0.97% | +0.97 |
| VRDN Viridian Therapeutics Inc. | New | 0.73% | +0.73 |
| CABA Cabaletta Bio Inc. | New | 0.34% | +0.34 |
| CHYM Chime Financial Inc. Class A | New | 0.28% | +0.28 |
| ORIC Oric Pharmaceuticals Inc. | Add +166.7% | 0.66% | +0.15 |
| HELP Cybin Inc. | New | 0.06% | +0.06 |
| CELC Celcuity Inc. | New | 0.02% | +0.02 |
| VOD Vodafone Group PLC-SP ADR | New | 0.01% | +0.01 |
| MRNO Murano Global Investments PL | New | 0.01% | +0.01 |
| PVLA Palvella Therapeutics Inc. | Add +16.0% | 0.84% | −0.21 |
| STWD Starwood Property Trust Inc. | Add +23.9% | 0.49% | −0.25 |
| EVMN Evommune Inc. | Add +80.0% | 0.36% | −0.26 |
| LENZ Lenz Therapeutics Inc. | Add +49.3% | 0.65% | −0.60 |
| CRVS Corvus Pharmaceuticals Inc. | Add +11.7% | 1.38% | −0.77 |
| HLLY Holley Inc. | Add +3.3% | 1.70% | −1.82 |
| CMPX Compass Therapeutics Inc. | Add +23.2% | 1.21% | −3.00 |
| LRMR Larimar Therapeutics Inc. | Add +28.7% | 4.26% | −4.41 |
Options Activity Q1 2026 → Q2 2026
| COMPASS PATHWAYS PLC | call | New | 1,670,500 | $5.2M |
| ERASCA INC | call | New | 100,000 | $795K |
| ELEDON PHARMACEUTICALS INC | call | New | 200,000 | $285K |
| LARIMAR THERAPEUTICS INC | call | New | 728,600 | $146K |
| COMPASS THERAPEUTICS INC | call | New | 303,800 | $106K |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q1 2026 → Q2 2026
| OPTXW Omnilit Acquisition Class A -23 | *W EXP 99/99/999 | Sold out | 803,132 | $867Kbefore exit |
| NIOBW Niocorp Developments Ltd. -28 | *W EXP 03/17/202 | Reduce -16.2% | 268,280 | $381K |
| BNAIW Brand Engagement Netwo -CW27 | *W EXP 03/14/202 | Reduce -12.8% | 1,453,808 | $204K |
| USDEW Stablecoinx Inc. | *W EXP 06/25/203 | New | 250,000 | $103K |
| ZEOWW Esgen Acquisition A -CW23 | *W EXP 03/13/202 | New | 250,000 | $10K |
| LVWR.WS Livewire Group Inc.-27 | *W EXP 09/26/202 | New | 400,000 | $8K |
| NVNWF Nvni Group Ltd.-28 | *W EXP 11/01/202 | New | 200,000 | $6K |
| BTMWQ Bitcoin Depot Inc.-CW23 | *W EXP 06/30/202 | Sold out | 50,000 | $1Kbefore exit |
| KPLTW Katapult Holdings Inc. -CW26 | *W EXP 06/09/202 | Sold out | 400,000 | $0before exit |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 48 | $656.7M | SPCX, AKTS, CGEM, LRMR, NCDL |
| Q1 2026 | 54 | $369.9M | AKTS, LRMR, ENGN, NCDL, CGEM |
| Q4 2025Amended | 50 | $320.9M | ENGN, NCDL, OBDC, LRMR, CGEM |
| Q3 2025 | 46 | $319.9M | NCDL, OBDC, ENGN, LRMR, EVCM |
| Q2 2025 | 46 | $308.2M | NCDL, OBDC, CGEM, EVCM, TRML |
| Q1 2025 | 45 | $309.2M | NCDL, OBDC, CGEM, EVCM, TRML |
| Q4 2024 | 48 | $432.6M | NCDL, KVYO, PLRX, OBDC, CGEM |
| Q3 2024 | 68 | $514.6M | NCDL, KVYO, TRML, PLRX, CGEM |
| Q2 2024 | 40 | $359.5M | CGEM, PLRX, OBDC, KVYO, LRMR |
| Q1 2024 | 44 | $500.6M | HOOD, CGEM, PLRX, ENGN, TRML |